November 28, 2015
1 min read
Save

High 2-year survivorship found for labral tears treated with hip arthroscopy in older patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Although investigators discovered an overall 2-year procedure survivorship of 70% for older patients who underwent hip arthroscopy for the treatment of labral tears, they highlighted that patients should be counseled prior to surgery about the potential of conversion to total hip arthroplasty.

Researchers retrospectively reviewed data on 30 patients aged 60 years or older who underwent arthroscopic hip surgery for labral tears and had a minimum 2-year follow-up. Data recorded included demographics, postoperative revision and conversion to total hip arthroplasty (THA). In addition, investigators collected a modified Harris Hip Score (mHHS), Non-Arthritic Hip Score, Hip Outcome Score Activities of Daily Living (HOS-ADL), Hip Outcome Score Sports Specific Subscale (HOS-SSS), VAS pain scores and measures of patient satisfaction. The mean follow-up period was 2.5 years.

Investigators found nine patients underwent conversion to THA at a mean of 1.1 years after hip arthroscopy. During the study period, two patients needed additional surgery.

In addition, all scores significantly improved from preoperative values with the exception of the HOS-SSS. Investigators discovered mean VAS scores decreased from 5 preoperatively to 2.7 postoperatively.

A subgroup analysis showed lower preoperative mHHS, lower preoperative HOS-ADL scores, higher VAS pain scores, greater acetabular inclination and more severe chondral damage in patients who required conversion to THA compared with patients who did not. by Monica Jaramillo

Disclosures: Redmond reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.